GSK vs UBSI · P/E 13, $103.31B cap vs P/E 14, rev $834.1M
GlaxoSmithKline PLC ADR (GSK) versus United Bankshares Inc (UBSI) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
United Bankshares Inc (UBSI) is a banks - regional company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported UBSI revenue for 2026-06-30 was $834.1M. Net income was $255.6M. UBSI currently screens at market cap $5.46B and trailing P/E 14.2.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. UBSI currently screens at market cap $5.46B and trailing P/E 14.2.
Not investment advice. Open the GSK and UBSI stock pages for the full models.
Not investment advice.